Skip to main content

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Investor Investigation Over Potential Wrongdoing In Acquisition Announced

  • If you purchased shares of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) and currently hold any of those NASDAQ:AUXL shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

October 17, 2014 (Update) - On September 17, 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) confirmed that it had received an unsolicited, non-binding proposal from Endo International plc (NASDAQ: ENDP) to acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) common stock at a price of$28.10 per share in cash and Endo International plc (NASDAQ: END) ...



You must register (for free) or login to view the entire investigation.